Influence of therapy with metformin on the concentration of certain divalent cations in patients with non-insulin-dependent diabetes mellitus

Biological Trace Element Research

Volumn 142, Issue 1, 2011, Pages 36-46

  Doşa, Monica Daniela ^a,b   Hangan, Laurentiu Tony ^a   Crauciuc, Eduard ^b   Galeş, Cristina ^b   Nechifor, Mihai ^b  

^a OVIDIUS UNIVERSITY   (Romania)

^b GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Copper; Magnesium; Metformin; NIDDM; Plasma glucose; Zinc

Indexed keywords

CHOLESTEROL; COPPER ION; DIVALENT CATION; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MAGNESIUM ION; METFORMIN; TRIACYLGLYCEROL; ZINC ION;

ADULT; ARTICLE; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; DRUG ACTIVITY; DRUG EFFECT; DRUG RESPONSE; ERYTHROCYTE LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID METABOLISM; MAGNESIUM BLOOD LEVEL; MAGNESIUM URINE LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; TREATMENT DURATION; ZINC BLOOD LEVEL; ZINC URINE LEVEL;

ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CATIONS, DIVALENT; CHOLESTEROL; COPPER; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MAGNESIUM; MALE; METFORMIN; MIDDLE AGED; TRACE ELEMENTS; ZINC;

EID: 79959569287     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-010-8751-9     Document Type: Article

References (42)

1. Prasad AS (1998) Zinc in human health: an update. J Trace Elem Exp Med 11:63-87
2. Saris NE, Mervaala E, Karippanem H, Khawaya JA, Lewenstam A (2000) Magnesium. An update on physiological clinical and analytical aspects. Clin Chem Acta 294:1-29
3. Opara E (2002) Oxidative stress, micronutrients, diabetes mellitus and its complications. J R Soc Health 122:28-34
4. Davi G, Falco A, Patrono C (2005) Lipid peroxidation in diabetes mellitus. Antioxid Redox Signal 7:256-268 (Pubitemid 40187942)
5. Kiliari S, Pullakhandam R, Nair KM (2010) Zinc inhibits oxidative stress induced iron signaling and apoptosis in caco-2 cells. Free Radic Biol Med 48(7):961-968
6. Upadhyay R, Panda SK (2010) Zinc reduces copper toxicity induced oxidative stress by promoting antioxidant defense in freshly grown aquatic duckweed Spirodela polyrhiza. J Hazard Mater 175(1-3):1081-1084
7. Giluder EM, Heth DA (1971) Colorimetric determination with bound "calmagite" of magnesium in human blood plasma. Clin Chem 17:663-666
8. Mann CK, Yoe JH (1956) Spectrophotometric determination ofmagnesiumwith sodium1-Azo-2-hydroxy-3-(2, 4-dimethylcarboxanilido)-naphthalene-1′-(2- hydroxybenzene-5-sulfonate). Anal Chem 28:202-205
9. Zervas E, Papatheodorou G, Psathakis K, Panagou P, Georgatou N, Loukudes S (2003) Reduced intracellular Mg concentrations in patients with acute asthma. Chest 123:113-118 (Pubitemid 36126722)
10. Longo R (2010) Diabetes under control: understanding oral antidiabetic agents. Am J Nurs 110(2):49-52
11. Green J, Feinglos M (2008) New combination treatments in the management of diabetes: focus on sitagliptin-metformin. Vasc Health Risk Manag 4(4):743-751
12. National Institute for Health and Clinical Excellence (2008) The management of type 2 diabetes (update). (Clinical guideline 66). NICE, London
13. Klip A, Leiter LA (1990) Cellular mechanism of action of metformin. Diab Care 13:696-704 (Pubitemid 20169149)
14. Gorelik O, Efrati S, Berman S, Almozino-Sarafian D, Shteinshnaider M, Cohen N (2007) Effect of various clinical variables on total intracellular magnesium in hospitalized normomagnesemic diabetic patients before discharge. Biol Trace Elem Res 120(1-3):102-109 (Pubitemid 350085212)
15. Lima ML, Cruz T, Rodriguez LE, Bomfim O, Melo J, Correia R, Porto M, Cedro A, Vicente E (2009) Serum and intracellular Mg deficiency in patients with metabolic syndrome. Evidences for its relation to insulin resistance. Diabetes Res Clin Pract 83(2):257-262
16. Kandeel FR, Balon E, Scott S, Nadler JL (1996) Magnesium deficiency and glucose metabolism in rat adipocytes. Metab Clin Exp 45(7):838-843 (Pubitemid 26249749)
17. Guerrero-Romero F, Tamez-Perez HE, Gonzáles-Gonzáles G, Sarinas-Martinez AM, Montes-Villarreal J, Treviño-Ortiz JH, Rodriguez-Moran M (2004) Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab 30(3):253-258 (Pubitemid 38917455)
18. Takaya J, Higashino H, Kobayashi Y (2004) Intracellular magnesium and insulin resistance. Magnes Res 171(2):126-136 (Pubitemid 39107248)
19. Humphries S, Kushner H, Falkner B (1999) Low dietary magnesium is associated with insulin resistance in a sample of young non diabetic Black Americans. Am J Hypertens 12:747-756 (Pubitemid 29416789)
20. Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R (1993) Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 21(6):1024-1029 (Pubitemid 23166961)
21. Barbagallo M, Dominguez LJ (2007) Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin-resistance. Arch Biochem Biophyis 458(1):40-47 (Pubitemid 46186226)
22. Banza J, Ortiz J, Dahan M, Justiniano M, Saenz R, Velez M (1998) Reliability of serum magnesium during diabetic ketoacidosis in children. Bol Asoc Méd PR 90:108-112
23. Corica F, Allegro A, Ientile R, Buemi M, Corsonello A, D'Angelo R, Bonanzinga S, Cucinotta D, Ceruso D (1997) Reduced intraplatelet magnesium concentrations in elderly patients with non-insulin dependent diabetes mellitus (NIDDM). Arch Gerontol Geriatr 25(3):255-262 (Pubitemid 27450390)
24. Ewis SA, Abdel-Rahman MS (1997) Influence of atenolol and/or metformin on glutathione and magnesium levels in diabetic rats. J Appl Toxicol 17(6):409-413 (Pubitemid 27514464)
25. Guerrero-Romero F, Rodriquez-Morán M (2005) Complementary therapies for diabetes: the case for chromium, magnesium, and antioxidants. Arch Med Res 36(3):250-257 (Pubitemid 40755138)
26. Kishimoto Y et al (2010) Effects of magnesium on postprandial serum lipid responses in healthy human subjects. Br J Nutr 103(4):469-472
27. Takeda R, Nakamura T (2008) Effects of high magnesium intake on bone mineral status and lipid metabolism in rats. J Nutr Sci Vitaminol 54(1):66-75 (Pubitemid 351413105)
28. Rosenstock J et al (2010) The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy. Diabets Care 10:2337
29. Glueck CJ, Goldenberg N, Wang P (2009) Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab 22(9):815-826
30. Hashemipour M et al (2009) Effect of zinc supplementation on insulin resistance and components of the metabolic syndrome in prepubertal obese children. Hormones 8(4):279-285
31. Partide-Hernández G, Arreola F, Fenton B, Carbeza M, Román-Ramos R, Revilla-Monsalve MC (2006) Effect of zinc replacement on lipids and lipoproteins in type 2-diabetic patients. Biomed Pharmacother 60(4):161-168
32. Lopez-Ridaura R, Willet WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, Hu FB (2004) Magnesium intake and risk of type 2 diabetes in men and women. Diab Care 27:134-140 (Pubitemid 38196722)
33. Rayssiguier Y, Gueux E, Nowacki W, Rock E, Mazur A (2006) High fructose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation. Magnes Res 19(4):237-243 (Pubitemid 46361325)
34. Guerrero-Romerro F, Rodriguez-Morán M (2006) Hypomagnesemia, oxidative stress, inflammation and metabolic syndrome. Diab Metab Rev 22(6):471-476
35. Barbagallo M, Dominguez LJ (2007) Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin-resistance. Arch Biochem Biophys 458(1):40-47 (Pubitemid 46186226)
36. De Valk HW (1999) Magnesium in diabetes mellitus. Neth J Med 54(4):139-146
37. Garland HO (1992) New experimental data on the relationship between diabetes mellitus and magnesium. Magnes Res 5(3):193-202
38. Tanaka A, Kaneto H, Miyatsura T, Yamamoto K, Yoshiuchi K, Shimomura I, Matsuoka T-A, Matsuhisa M (2009) Role of copper ion in the pathogenesis of type 2 diabetes. Endocr J 56(5):699-706
39. Cai L, Li XK, Song Y, Cherian MG (2005) Essentiality, toxicology and chelation therapy of zinc and cooper. Curr Med Chem 12(23):2755-2763
40. Kazi TG, Afridi HI, Kazi N, Jamali MK, Arain MB, Jalbani N, Kandhro GA (2008) Copper, chromium, manganese, iron, nickel and zinc levels in biological samples of diabetes mellitus patients. Biol Trace Elem Res 122(1):1-18
41. Walter RM, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, Critchfield JW, Keen CL (1991) Copper, zinc, manganese and magnesium status and complications of diabetes mellitus. Diab Care 14(11):1050-1056
42. Cooper GJ, Chan YK, Dissanayake AM, Leahy FE, Keogh GF, Frampton CM, Gamble GD, Brunton DH, Baker JR, Poppitt SD (2005) Demonstration of a hyperglicemia-driven pathogenic abnormality of cooper homeostasis in diabetes and its reversibility by selective chelation: quantitative comparisons between the biology of copper and eight other nutritionally essential elements in normal and diabetic individuals. Diabetes 54(5):1468-1476